Adrian joined OGT as Chief Executive Officer in March 2022. Adrian has spent over 20 years in the diagnostics industry, with extensive experience in strategy, general management and mergers and acquisitions.
Adrian has a history of delivering significant growth through commercial and operational excellence and through the acquisition and integration of businesses and technologies in the diagnostics space.
Prior to joining OGT Adrian was General Manager of the diagnostics, imaging and surgical divisions at Hologic. Previously Adrian was responsible for the EMEA women’s health and screening businesses at Qiagen, and the personalised medicine and Business Development functions at Roche Diagnostics.